ODT MLaaS and RPAaaS Platform Administration
Past New Requirement Updated
- Agency
-
Food and Drug Administration
Department of Health and Human Services
- Solicitation expected
- Estimated value
- $3,000,000 to $7,000,000
- Set-aside
- No set-aside
Forecast facts
- Anticipated award
- NAICS code
- 511210 Software Publishers
- Points of contact
-
- Christopher Scott christopher.scott@fda.hhs.gov
- tbd@fda.gov
Forecast details come from HHS's procurement forecast. Agencies' dates and values are estimates.
About this forecast
The Food and Drug Administration (FDA) is seeking a Machine Learning as a Service (MLaaS) and Robotic Process Automation as a Service (RPAaaS) Platform Administration solution. This new requirement is classified under the Software Publishers NAICS code 511210, with an estimated solicitation release date of February 1, 2026, and a projected award date of April 1, 2026. The procurement aims to provide machine learning tools that can be adopted by the organization to support its operational needs.
While specific budget details are not provided, the contract will be pursued without a set-aside designation, potentially opening the opportunity to a broad range of technology service providers. The primary point of contact for this opportunity is Christopher Scott, who can be reached at christopher.scott@fda.hhs.gov within the Food and Drug Administration. Additional contact information includes a TBD mailbox at tbd@fda.gov, and interested vendors should monitor the solicitation for further details about the platform administration services.
Forecast text
Machine Learning as a Service (MLaaS) is a set of services that offer machine learning tools that can be adopted by any organization as a part of their working needs.
On GovTribe
Work this forecast
- Track it in your pipeline
- Find teaming partners
- Similar forecasts
- Ask GovTribe AI about this forecast